Author
Listed:
- Masanori Miyata
(Center for Inflammation, Immunity & Infection, Institute for Biomedical Sciences, Georgia State University)
- Ji-Yun Lee
(Center for Inflammation, Immunity & Infection, Institute for Biomedical Sciences, Georgia State University)
- Seiko Susuki-Miyata
(Center for Inflammation, Immunity & Infection, Institute for Biomedical Sciences, Georgia State University)
- Wenzhuo Y. Wang
(Center for Inflammation, Immunity & Infection, Institute for Biomedical Sciences, Georgia State University
University of Rochester Medical Center)
- Haidong Xu
(Center for Inflammation, Immunity & Infection, Institute for Biomedical Sciences, Georgia State University)
- Hirofumi Kai
(Graduate School of Pharmaceutical Sciences, Kumamoto University)
- Koichi S. Kobayashi
(College of Medicine, Texas A&M Health Science Center)
- Richard A. Flavell
(Yale University School of Medicine)
- Jian-Dong Li
(Center for Inflammation, Immunity & Infection, Institute for Biomedical Sciences, Georgia State University)
Abstract
Glucocorticoids are among the most commonly used anti-inflammatory agents. Despite the enormous efforts in elucidating the glucocorticoid-mediated anti-inflammatory actions, how glucocorticoids tightly control overactive inflammatory response is not fully understood. Here we show that glucocorticoids suppress bacteria-induced inflammation by enhancing IRAK-M, a central negative regulator of Toll-like receptor signalling. The ability of glucocorticoids to suppress pulmonary inflammation induced by non-typeable Haemophilus influenzae is significantly attenuated in IRAK-M-deficient mice. Glucocorticoids improve the survival rate after a lethal non-typeable Haemophilus influenzae infection in wild-type mice, but not in IRAK-M-deficient mice. Moreover, we show that glucocorticoids and non-typeable Haemophilus influenzae synergistically upregulate IRAK-M expression via mutually and synergistically enhancing p65 and glucocorticoid receptor binding to the IRAK-M promoter. Together, our studies unveil a mechanism by which glucocorticoids tightly control the inflammatory response and host defense via the induction of IRAK-M and may lead to further development of anti-inflammatory therapeutic strategies.
Suggested Citation
Masanori Miyata & Ji-Yun Lee & Seiko Susuki-Miyata & Wenzhuo Y. Wang & Haidong Xu & Hirofumi Kai & Koichi S. Kobayashi & Richard A. Flavell & Jian-Dong Li, 2015.
"Glucocorticoids suppress inflammation via the upregulation of negative regulator IRAK-M,"
Nature Communications, Nature, vol. 6(1), pages 1-12, May.
Handle:
RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms7062
DOI: 10.1038/ncomms7062
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms7062. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.